Concert Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Concert Pharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $1.90 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-11-07
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $1.90M, a 39.28% decline year-over-year.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $1.96M, a 39.64% decline year-over-year.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $2.11M, a 38.47% decline year-over-year.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $2.76M, a 5.92% decline year-over-year.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2021 was $12.57M, a 13.13% increase from fiscal 2020.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2020 was $11.11M, a 7.62% increase from fiscal 2019.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2019 was $10.33M, a 10.21% decline from fiscal 2018.
- Concert Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2018 was $11.50M, a 35.29% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.90M 10-Q · filed 2022-11-07 | $3.86M derived: sum of 2 quarters · filed 2022-11-07 | $5.97M 10-Q · filed 2022-11-07 | $8.73M derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | $1.96M 10-Q · filed 2022-08-04 | $4.07M 10-Q · filed 2022-08-04 | $6.84M derived: sum of 3 quarters · filed 2022-08-04 | $9.96M derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-03-31 | $2.11M 10-Q · filed 2022-05-05 | $4.87M derived: sum of 2 quarters · filed 2022-05-05 | $8.00M derived: sum of 3 quarters · filed 2022-11-07 | $11.25M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.89M derived: sum of 2 quarters · filed 2022-11-07 | $9.14M derived: sum of 3 quarters · filed 2022-11-07 | $12.57M 10-K · filed 2022-03-03 |
| 2021-09-30 | $3.12M 10-Q · filed 2022-11-07 | $6.38M derived: sum of 2 quarters · filed 2022-11-07 | $9.81M 10-Q · filed 2022-11-07 | $12.75M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $3.25M 10-Q · filed 2022-08-04 | $6.68M 10-Q · filed 2022-08-04 | $9.62M derived: sum of 3 quarters · filed 2022-08-04 | $12.52M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $3.43M 10-Q · filed 2022-05-05 | $6.37M derived: sum of 2 quarters · filed 2022-05-05 | $9.26M derived: sum of 3 quarters · filed 2022-05-05 | $12.07M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.83M derived: sum of 2 quarters · filed 2022-03-03 | $8.64M derived: sum of 3 quarters · filed 2022-03-03 | $11.11M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.90M 10-Q · filed 2021-11-09 | $5.70M derived: sum of 2 quarters · filed 2021-11-09 | $8.18M 10-Q · filed 2021-11-09 | $10.79M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.80M 10-Q · filed 2021-08-05 | $5.28M 10-Q · filed 2021-08-05 | $7.90M derived: sum of 3 quarters · filed 2021-08-05 | $10.32M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.48M 10-Q · filed 2021-05-04 | $5.09M derived: sum of 2 quarters · filed 2021-05-04 | $7.51M derived: sum of 3 quarters · filed 2021-05-04 | $9.87M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.04M derived: sum of 2 quarters · filed 2021-02-25 | $7.40M derived: sum of 3 quarters · filed 2021-02-25 | $10.33M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.42M 10-Q · filed 2020-11-05 | $4.78M derived: sum of 2 quarters · filed 2020-11-05 | $7.71M 10-Q · filed 2020-11-05 | $10.38M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.36M 10-Q · filed 2020-08-06 | $5.29M 10-Q · filed 2020-08-06 | $7.96M derived: sum of 3 quarters · filed 2020-08-06 | $10.69M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $2.93M 10-Q · filed 2020-04-30 | $5.59M derived: sum of 2 quarters · filed 2020-04-30 | $8.33M derived: sum of 3 quarters · filed 2020-04-30 | $11.13M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.40M derived: sum of 2 quarters · filed 2020-02-27 | $8.20M derived: sum of 3 quarters · filed 2020-02-27 | $11.50M 10-K · filed 2020-02-27 |
| 2018-09-30 | $2.73M 10-Q · filed 2019-11-07 | $5.54M derived: sum of 2 quarters · filed 2019-11-07 | $8.83M 10-Q · filed 2019-11-07 | $11.62M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $2.80M 10-Q · filed 2019-08-01 | $6.10M 10-Q · filed 2019-08-01 | $8.89M derived: sum of 3 quarters · filed 2019-08-01 | $11.39M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $3.30M 10-Q · filed 2019-05-02 | $6.09M derived: sum of 2 quarters · filed 2019-05-02 | $8.58M derived: sum of 3 quarters · filed 2019-05-02 | $10.16M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.28M derived: sum of 2 quarters · filed 2019-02-28 | $6.86M derived: sum of 3 quarters · filed 2019-02-28 | $8.50M 10-K · filed 2019-02-28 |
| 2017-09-30 | $2.50M 10-Q · filed 2018-11-01 | $4.07M derived: sum of 2 quarters · filed 2018-11-01 | $5.71M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $1.57M 10-Q · filed 2018-08-02 | $3.22M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $1.64M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | $5.07M 10-K · filed 2019-02-28 |